Altay Therapeutics is focused on developing small molecules that target transcription factors to address serious diseases, including facioscapulohumeral muscular dystrophy (FSHD) and various cancers
Altay Therapeutics is focused on developing small molecules that target transcription factors to address serious diseases, including facioscapulohumeral muscular dystrophy (FSHD) and various cancers.